No Detail Found!

Lymphopenia is an indicator of severity of the disease and predicts mortality in COVID-19.

Author(s)
Saiqa Zahoor Hayatabad Medical Complex, Peshawar, Pakistan
Ayesha Sarwar Hayatabad Medical Complex, Peshawar, Pakistan
Khalid Khan Hayatabad Medical Complex, Peshawar, Pakistan
Hamzullah Khan Nowshera Medical College, Pakistan
Shahtaj Khan Hayatabad Medical Complex, Peshawar.Pakistan
Ansa Rehman Hayatabad Medical Complex, Peshawar.Pakistan
Huma Riaz Hayatabad Medical Complex, Peshawar.Pakistan
Abstract
Objectives: To assess the impact of lymphopenia on the COVID-19 disease outcome. Study Design: Retrospective study. Setting: ICU and Isolation Ward of Hayatabad Medical Complex, Peshawar. Period: July 2020 to Dec 2020. Material & Methods: Different parameters of CBC were performed using the five parts Sysmex differential hematology analyzer BS-1800. A total of 274 patients were included via non probability sampling. Relevant information's were recorded on a pre-designed performa prepared in accordance with the objectives of the study. Results: The absolute lymphocyte count was lower in patients who were admitted in ICU as compared to those in isolation ward (p-value 0.07). Likewise patients with severe lymphocytopenia (lymphocyte count less than 50x10*9/L) had a greater rate of mortality (p value 0.01). No significant difference in term of TLC and ANC was noted in survivor's vs non survivors groups in present study. Conclusion: Our study concludes that lymphopenia serves as a reliable and early prognostic factor in determining disease severity and mortality COVID-19.
Publication Details
Page(s) 527-531
Published Journal: Professional Medical Journal, Volume: 29, Issue: 4, Year: 2022

Request the full text from PASTIC

Keywords
Mortality., COVID-19, Lymphopenia, Covid-19
0

Citations

0

Downloads

49

Views